China backs talks on intellectual property waiver for COVID-19 vaccines | Inquirer News

China backs talks on intellectual property waiver for COVID-19 vaccines

/ 07:29 PM May 13, 2021

A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed China flag in this illustration

FILE PHOTO: A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed China flag in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo

BEIJING — China’s Commerce Ministry spokesman Gao Feng said on Thursday that Beijing supports a proposal by the World Trade Organization for an intellectual property protection waiver on COVID-19 vaccines to enter the consultation stage.

British and European Union officials have been skeptical about the usefulness of a U.S. proposal to waive patent protections for COVID-19 vaccines, while saying they are prepared to discuss it.

Article continues after this advertisement

Drugmakers and some other governments opposed the idea, saying it would not solve global inoculation shortages.

FEATURED STORIES

“China supports the WTO’s proposal on IP exemptions for anti-epidemic materials such as the COVID vaccine to enter the text consultation stage,” Gao said at a regular news conference in Beijing.

“China will work with all parties to actively participate in consultations and jointly promote a balanced and effective solution,” he said.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: China

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.